Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Irena Tomaszewska

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Molecular Pharmaceutics|October 25, 2023
Digitalizing the TIM-1 Model using Computational Approaches-Part One: TIM-1 Data ExplorerInese Sarcevica, Bart Hens, Irena Tomaszewska, et al.
Molecular Pharmaceutics|October 25, 2023
Digitalizing the TIM-1 Model Using Computational Approaches─Part Two: Digital TIM-1 Model in GastroPlusBart Hens, Inese Sarcevica, Irena Tomaszewska, et al.
International Journal of Pharmaceutics|June 4, 2013
Pharmaceutical characterisation and evaluation of cocrystals: Importance of in vitro dissolution conditions and type of coformerIrena Tomaszewska, Shyam Karki, Jag Shur, et al.
Molecular Pharmaceutics|April 10, 2023
Effect of Food and a Proton-Pump Inhibitor on the Absorption of Encorafenib: An <i>In Vivo</i>-<i>In Vitro</i>-<i>In Silico</i> ApproachJoseph Piscitelli, Bart Hens, Irena Tomaszewska, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|June 21, 2016
Can dosage form-dependent food effects be predicted using biorelevant dissolution tests? Case example extended release nifedipineCord J Andreas, Irena Tomaszewska, Uwe Muenster, et al.
Journal of Pharmaceutical Sciences|October 21, 2021
In Vitro Simulation of the Environment in the Upper Gastrointestinal Lumen After Drug Administration in the Fed State Using the TIM-1 System and Comparison With Luminal Data in AdultsChristina Pentafragka, Irena Tomaszewska, Susann Bellmann, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 19, 2024
Can in vitro/in silico tools improve colonic concentration estimations for oral extended-release formulations? A case study with upadacitinibAlessia Favaron, Bart Hens, Maiara Camotti Montanha, et al.
Molecular Pharmaceutics|March 3, 2021
Investigating the Impact of Crohn's Disease on the Bioaccessibility of a Lipid-Based Formulation with an In Vitro Dynamic Gastrointestinal ModelAngela Effinger, Mark McAllister, Irena Tomaszewska, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|May 4, 2019
Biorelevant dissolution testing of a weak base: Interlaboratory reproducibility and investigation of parameters controlling in vitro precipitationPhilippe Berben, Lee Ashworth, Stefania Beato, et al.
Molecular Pharmaceutics|July 25, 2017
Validation of Dissolution Testing with Biorelevant Media: An OrBiTo StudyJames Mann, Jennifer Dressman, Karin Rosenblatt, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Molecular Pharmaceutics|October 25, 2023
Digitalizing the TIM-1 Model using Computational Approaches-Part One: TIM-1 Data ExplorerInese Sarcevica, Bart Hens, Irena Tomaszewska, et al.
Molecular Pharmaceutics|October 25, 2023
Digitalizing the TIM-1 Model Using Computational Approaches─Part Two: Digital TIM-1 Model in GastroPlusBart Hens, Inese Sarcevica, Irena Tomaszewska, et al.
International Journal of Pharmaceutics|June 4, 2013
Pharmaceutical characterisation and evaluation of cocrystals: Importance of in vitro dissolution conditions and type of coformerIrena Tomaszewska, Shyam Karki, Jag Shur, et al.
Molecular Pharmaceutics|April 10, 2023
Effect of Food and a Proton-Pump Inhibitor on the Absorption of Encorafenib: An <i>In Vivo</i>-<i>In Vitro</i>-<i>In Silico</i> ApproachJoseph Piscitelli, Bart Hens, Irena Tomaszewska, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|June 21, 2016
Can dosage form-dependent food effects be predicted using biorelevant dissolution tests? Case example extended release nifedipineCord J Andreas, Irena Tomaszewska, Uwe Muenster, et al.
Journal of Pharmaceutical Sciences|October 21, 2021
In Vitro Simulation of the Environment in the Upper Gastrointestinal Lumen After Drug Administration in the Fed State Using the TIM-1 System and Comparison With Luminal Data in AdultsChristina Pentafragka, Irena Tomaszewska, Susann Bellmann, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 19, 2024
Can in vitro/in silico tools improve colonic concentration estimations for oral extended-release formulations? A case study with upadacitinibAlessia Favaron, Bart Hens, Maiara Camotti Montanha, et al.
Molecular Pharmaceutics|March 3, 2021
Investigating the Impact of Crohn's Disease on the Bioaccessibility of a Lipid-Based Formulation with an In Vitro Dynamic Gastrointestinal ModelAngela Effinger, Mark McAllister, Irena Tomaszewska, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|May 4, 2019
Biorelevant dissolution testing of a weak base: Interlaboratory reproducibility and investigation of parameters controlling in vitro precipitationPhilippe Berben, Lee Ashworth, Stefania Beato, et al.
Molecular Pharmaceutics|July 25, 2017
Validation of Dissolution Testing with Biorelevant Media: An OrBiTo StudyJames Mann, Jennifer Dressman, Karin Rosenblatt, et al.
Pageof 2